Yesterday, the Competition Bureau registered a consent agreement with the Competition Tribunal to address its concerns related to certain aspects of the proposed formation of a gas processing joint venture between Pembina Pipeline Corporation and KKR’s Global Infrastructure Funds.
The Competition Bureau has closed its preliminary investigation into potential anti-competitive harm from relabelled biologic drugs. Relabelled biologic drugs are identical to originator biologic drugs but marketed under a secondary brand name.
The Competition Bureau encourages all procurement agents in Canada to take advantage of its newly-launched Collusion Risk Assessment Tool to help them protect their procurement processes from bid-rigging.
The Competition Bureau announced today that it has reached an agreement with Neighbourly Pharmacy Inc. to resolve competition concerns related to its proposed acquisition of Rubicon Pharmacies in Western Canada.
The Competition Bureau has approved Kruger Inc. as the purchaser of Paper Excellence’s pulp mill in Kamloops, British Columbia, as required by an agreement that the mill be sold as part of Paper Excellence’s acquisition of Domtar Corp.